Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC).
Catherine Wei Min OngGiovanni Battista MiglioriMario RaviglioneGavin MacGregor-SkinnerGiovanni SotgiuJan-Willem AlffenaarSimon TiberiCornelia AdlhochTonino AlonziSophia ArchuletaSergio BrusinEmmanuelle CambauMaria Rosaria CapobianchiConcetta CastillettiRosella CentisDaniela Maria CirilloRosella CentisGiovanni DeloguSusanna M R EspositoJose FigueroaJon S FriedlandBenjamin Choon Heng HoGiuseppe IppolitoMateja Jankovic MakekHannah Yejin KimSenia Rosales KlintzCsaba KödmönEleonora LalleYee Sin LeoChi-Chiu LeungAnne-Grete MärtsonMario Giovanni MelazziniSaeid Najafi FardPasi PenttinenLinda PetroneElisa PetruccioliEmanuele PontaliLaura SaderiMiguel SantinAntonio SpanevelloReinout van CrevelMarieke J van der WerfDina ViscaMiguel ViveirosJean-Pierre ZellwegerAlimuddin ZumlaDelia GolettiPublished in: The European respiratory journal (2020)
Major epidemics, including some that qualify as pandemics, such as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), HIV, influenza A (H1N1)pdm/09 and most recently COVID-19, affect the lung. Tuberculosis (TB) remains the top infectious disease killer, but apart from syndemic TB/HIV little is known regarding the interaction of viral epidemics and pandemics with TB. The aim of this consensus-based document is to describe the effects of viral infections resulting in epidemics and pandemics that affect the lung (MERS, SARS, HIV, influenza A (H1N1)pdm/09 and COVID-19) and their interactions with TB. A search of the scientific literature was performed. A writing committee of international experts including the European Centre for Disease Prevention and Control Public Health Emergency (ECDC PHE) team, the World Association for Infectious Diseases and Immunological Disorders (WAidid), the Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycobacterial Infections (ESGMYC) was established. Consensus was achieved after multiple rounds of revisions between the writing committee and a larger expert group. A Delphi process involving the core group of authors (excluding the ECDC PHE team) identified the areas requiring review/consensus, followed by a second round to refine the definitive consensus elements. The epidemiology and immunology of these viral infections and their interactions with TB are discussed with implications for diagnosis, treatment and prevention of airborne infections (infection control, viral containment and workplace safety). This consensus document represents a rapid and comprehensive summary on what is known on the topic.
Keyphrases
- infectious diseases
- sars cov
- mycobacterium tuberculosis
- hiv aids
- public health
- clinical practice
- antiretroviral therapy
- respiratory syndrome coronavirus
- coronavirus disease
- pulmonary tuberculosis
- hiv positive
- hiv infected
- hepatitis c virus
- hiv testing
- palliative care
- men who have sex with men
- emergency department
- radiation therapy
- particulate matter
- quality improvement
- case report
- air pollution
- adverse drug
- drug induced